1.1 Psychopharmacologic Treatment of Depressive Disorders in Children and Adolescents

2017 ◽  
Vol 56 (10) ◽  
pp. S134
Author(s):  
Karen Dineen Wagner
Keyword(s):  
Children And Adolescents ◽  
Depressive Disorders

scholarly journals Evidencias de Validez Diagnóstica de la Escala Detectaweb-Malestar

2020 ◽  
Vol 25 (3) ◽  
pp. 161
Author(s):  
José A. Piqueras ◽  
Mariola García-Olcina ◽  
María Rivera-Riquelme ◽  
David Pineda
Keyword(s):  
Children And Adolescents ◽  
Emotional Disorders ◽  
Depressive Disorders ◽  
Point Of View ◽  
Diagnostic Process ◽  
Diagnostic Validity ◽  
Validity And Reliability ◽  
Palabras Clave ◽  
Anxiety Depression ◽  
Distress Scale

Evidence of diagnostic validity of the DetectaWeb-Distress ScaleAbstract: The DetectaWeb-Distress Scale is a web-based scale for screening and detecting internalizing disorder symptoms (anxiety, depression, posttraumatic stress, obsessions and compulsions, and suicidality) in children and adolescents. Previous studies examined the validity and reliability of the scale, however, there are no data on its diagnostic validity. The objective of this study was to examine the evidence of diagnostic validity of the DetectaWeb-Distress scale in a sample of 244 children and adolescents from clinical (n = 51) and community (n = 193) settings, all of them with the diagnostic process completed. The results indicated that the DetectaWeb-Distress scale is a useful measure from a diagnostic point of view, as it discriminates between people with emotional disorders such as anxiety and depressive disorders and suicidality, and those without, presenting ROC values of approximately .80 and good sensitivity and specificity for detecting the main emotional disorders. The DetectaWeb-Distress Scale is a valid measure and diagnostically useful for detecting and identifying children and adolescents with anxiety disorders, depression and suicidality, with the advantage that it is a short measure, specifically developed for Internet use, especially relevant in the era of COVID-19.Keywords: DetectaWeb-Distress; assessment, anxiety, depression, children, adolescents.Evidencias de Validez Diagnóstica de la Escala Detectaweb-Malestar Resumen: La Escala DetectaWeb-Malestar es una escala de detección del malestar emocional a través de internet que evalúa síntomas de trastornos interiorizados (ansiedad, depresión, estrés postraumático, obsesiones y compulsiones y suicidalidad) en niños y adolescentes. Estudios anteriores han examinado la validez y fiabilidad de la escala, sin embargo, no cuenta con datos relativos a su validez diagnóstica. El objetivo de este estudio es examinar las evidencias de validez diagnóstica de la escala DetectaWeb-Malestar en una muestra de 244 niños y adolescentes procedentes de contextos clínico (n = 51) y comunitario (n = 193), todos con un proceso diagnóstico completado. Los resultados indicaron que la escala DetectaWeb-Malestar es una medida útil desde el punto de vista diagnóstico, ya que discrimina entre personas con trastornos de emocionales, como son los de ansiedad, depresión y suicidalidad y los que no lo padecen, presentando valores ROC en torno a .80 y adecuada sensibilidad y especificidad para detectar los principales trastornos emocionales. La escala DetectaWeb-Malestar es una medida válida y útil desde el punto de vista diagnóstico para detectar e identificar niños y adolescentes con problemas de ansiedad, depresión y suicidalidad, con la ventaja de que es una medida breve y desarrollada específicamente para su uso a través de Internet, especialmente relevante en la era de la COVID-19.Palabras clave: DetectaWeb-Malestar; evaluación; ansiedad; depresión; niños y adolescentes.

scholarly journals PERCEPTIONS OF A MULTIDISCIPLINARY TEAM ON THE PSYCHOLOGICAL REPERCUSSIONS OF SEXUAL VIOLENCE AGAINST CHILDREN AND ADOLESCENTS

2021 ◽  
Vol 30 ◽  
Author(s):  
Marimeire Morais da Conceição ◽  
Breno de Oliveira Ferreira ◽  
Edsângela Thalita Passos Barreto ◽  
Carmen Lúcia Pereira Dias Nery ◽  
Jacilene Santiago do Nascimento Trindade dos Santos ◽  
...  
Keyword(s):  
Sexual Violence ◽  
Children And Adolescents ◽  
Multidisciplinary Team ◽  
Depressive Disorders ◽  
Psychological Disorders ◽  
Daily Basis ◽  
Warning Signs ◽  
Health Team ◽  
Team Working ◽  
Institutional Review

ABSTRACT Objective: to understand the perceptions of a multidisciplinary health team in caring for hospitalized children and adolescents with psychological repercussions of sexual violence, in the light of Symbolic Interactionism Theory. Method: this is a qualitative study, carried out with 30 professionals from the multidisciplinary health team working in a general public hospital in Salvador, Bahia, Brazil. The interviews took place between June and July 2019, using a semi-structured questionnaire and, after being recorded, the reports were transcribed. In analysis, the data were categorized by similar themes following the steps: pre-analysis, material exploration, treatment of results and interpretation. The project was approved by an Institutional Review Board. Results: among the psychological disorders presented by children and adolescents are aggressiveness, mutism, eating disorders, infantilized behavior, hypersexualized behaviors, depressive disorders, anxiety disorders, psychotic episodes, and delusions. Conclusion: the study demonstrates the perceptions resulting from the interaction allowed in caring for the multidisciplinary team to children and adolescents who experienced sexual violence and developed psychological disorders. In this way, it raises warning signs for family members, health professionals, education, protective devices and the whole of society about the need to observe signs of these changes on a daily basis, seeking to investigate their possible relationship with sexual assault.

scholarly journals Assessing the Evidence of Micronutrients on Depression among Children and Adolescents: An Evidence Gap Map

2020 ◽  
Vol 11 (4) ◽  
pp. 908-927
Author(s):  
Susan C Campisi ◽  
Clare Zasowski ◽  
Shailja Shah ◽  
Ashka Shah ◽  
Glyneva Bradley-Ridout ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Depressive Disorders ◽  
Unipolar Depression ◽  
Eligibility Criteria ◽  
Treatment Of Depression ◽  
Comprehensive Search ◽  
Major Depressive Disorders ◽  
Severity Of Depression ◽  
The Impact

ABSTRACT There is some evidence indicating that nutrition may have the ability to prevent, treat, and/or influence the severity of depression. The aims of this evidence gap map (EGM) are to provide an overview and to determine evidence gaps in the existing research on micronutrients and their impact on depression among children and adolescents. We conducted a comprehensive search in multiple databases of primary and secondary literature assessing the impact of micronutrients on depression-related outcomes such as unipolar depression, major depressive disorders, dysthymia, acute depression, and mood disorders. Abstracts and full-text articles were dual-screened based on predefined eligibility criteria. A total of 30 primary research publications were included in the EGM. About 47% of included studies focused on late adolescents (15–19 y), ∼40% on early adolescents (10–14 y), and ∼13% on children aged 6–9 y. Among the included studies, 8 studies examined a single micronutrient intervention and 22 studies examined micronutrient concentrations (either intake or serum), and their impact on depression. The most frequently studied micronutrients were vitamin D (n = 8), zinc (n = 8), iron (n = 6), folate (n = 7), and vitamin B-12 (n = 5). More longitudinal studies and trials are needed to determine the role of micronutrients in the etiology and treatment of depression among children and adolescents.

Child and Adolescent Depression

Depression ◽  
2019 ◽  
pp. 399-417
Author(s):  
Andrew Diederich ◽  
Jessica M. Jones ◽  
Graham J. Emslie
Keyword(s):  
Children And Adolescents ◽  
Early Onset ◽  
Adolescent Depression ◽  
Depressive Disorders ◽  
Future Research ◽  
Evidence Based ◽  
Research Directions ◽  
Psychosocial Impairment ◽  
Future Research Directions ◽  
Irritable Mood

Early onset depression is prevalent and causes significant morbidity, mortality, and psychosocial impairment. Evidence-based psychosocial and psychopharmacological treatments are available for depressed youth, but many children and adolescents do not receive sufficient treatment. Pediatric and adult depressive disorders involve essentially the same symptoms, with the exception of irritability, as depressed youth may present with irritable mood in the absence of explicit sadness. This chapter examines aspects of depression that are unique to children and adolescents. It focuses on diagnosis and symptomatology, epidemiology, and pharmacological, psychotherapeutic, and other treatments. The chapter also addresses barriers to treatment of early onset depression and future research directions.

scholarly journals Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials

2019 ◽  
Vol 13 (1) ◽  
Author(s):  
Li Zhang ◽  
Huan Liu ◽  
Li Kuang ◽  
Huaqing Meng ◽  
Xinyu Zhou
Keyword(s):  
Fatty Acids ◽  
Depressive Symptoms ◽  
Children And Adolescents ◽  
Depressive Disorders ◽  
Response Rate ◽  
Risk Of Bias ◽  
Controlled Trials ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Subgroup Analyses

Abstract Background To investigate the efficacy and safety of omega-3 fatty acids (O3FA) in treating depressive disorders in children and adolescents. Method We conducted a comprehensive search in electronic databases and hand-searched articles included for relevant studies. We included randomized controlled trials which studied on O3FA for treatment of children and adolescents with depression. The standard mean differences (SMDs) and the odds ratios (ORs) with 95% confidence intervals (CIs) were estimated by a random-effects model. The primary outcomes were end-point depressive symptoms scores (efficacy) and all-cause discontinuation (safety). The secondary outcome of response rate was also assessed. Subgroup analyses were performed by age, severity of depression and dosage. Risk of bias assessment was performed based on the Jadad score and the Cochrane Collaboration’s risk-of-bias method. Results A total of four studies with 153 participants were included. In terms of efficacy, there was no significant difference of end-point depressive symptoms scores between O3FA and placebo (SMD = − 0.12, 95% CI − 0.53 to 0.30, P = 0.58; I2= 30%). In terms of safety, the all-cause discontinuation showed no statistical significance between O3FA and placebo (OR = 1.3, 95% CI 0.58 to 2.93, P = 0.53; I2= 0%). The response rate of O3FA was also not significant better than that of placebo (OR = 1.57, 95% CI 0.26 to 9.39, P = 0.62; I2= 71%). Besides, there were also no significant differences in those subgroup analyses outcomes. The risk of bias of included trials were not high. Conclusions Only considering the limited evidence of O3FA in the acute treatment of major depressive disorder, it did not seem to offer a clear advantage for children and adolescents.

Sign in / Sign up

Export Citation Format

Share Document